RemedyRepack Recalls Bicillin L-A Due to Incorrect Storage Instructions
RemedyRepack, Inc. is recalling 60 vials of Bicillin L-A 600,000 Units/mL injection because the product labels contain incorrect storage instructions.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to incorrect storage instructions, which is a labeling error that may lead to temporary or medically reversible adverse health consequences, fitting the Moderate severity criteria.
Plain-English summary
RemedyRepack, Inc. is recalling 60 vials of Bicillin L-A 600,000 Units/mL Injection, NDC 61786-0253-03. The product was manufactured by King Pharma Inc. and repackaged by RemedyRepack, Inc. The recall is limited to specific lots: B0077329-040215 (Exp 07/2017), B0091342-070315 (Exp 08/2017), and B0109416-102815 (Exp 03/2018).
The recall was initiated because the product labels contain incorrect storage instructions. The FDA has classified this as a Class II recall, indicating a situation that might cause temporary or medically reversible adverse health consequences.
The affected products were distributed nationwide. Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be returned to the supplier or disposed of according to local regulations.
The recalled product
- Product
- Bicillin L-A 600000 Units/mL Inj., Qty: 20 mL Syringe, MFG by: King Pharma Inc., Bristol, TN 37620, Repackaged by: RemedyRepack, Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 61786-0253-03
- Manufacturer
- RemedyRepack Inc.
- Category
- Drug — Antibiotic Injection
- Affected units
- 60
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # B0077329-040215
- Exp 07/2017
- B0091342-070315
- Exp 08/2017
- B0109416-102815
- Exp 03/2018
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by RemedyRepack Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · RemedyRepack Inc.
See all →- ModerateClindamycin HCl Capsule 300 mg repackaged by RemedyRePack Inc.
FDA (Drugs) · 2025-05-14
- ModerateClindamycin HCl 300 mg Capsule Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-30
- HighCarvedilol 25 mg tablets recalled due to N-nitroso impurity above limit
FDA (Drugs) · 2025-02-12
- HighDuloxetine delayed-release capsules recalled due to manufacturing impurity
FDA (Drugs) · 2025-01-01
- HighPotassium Chloride Extended Release Capsules Recalled for Dissolution Defect
FDA (Drugs) · 2024-07-24
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02